These data indicate that epigenetic modification (DNA hypomethylation) at the Exon-1/Intron-1 region, but not a structural/genetic abnormality, might be a potential mechanism of HAMP upregulation in ccRCC tumors. This evidence concerns the gene HAMP and nonpapillary renal cell carcinoma.